Acute Myeloid Leukemia | Tumor

CURE’s acute myeloid leukemia page features the latest cancer news and updates on acute myeloid leukemia. Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in acute myeloid leukemia.

Many Thoughts Flooded My Mind When I Received a Cancer Diagnosis

November 9th 2022, 10:00pm

Article

“Was I OK with dying? Would I still be there for my dog? Can I still smoke?” — all these thoughts entered my mind when my oncologist told me that I had leukemia.

FDA to Prioritize Review of Oral Drug to Treat Common Type of Leukemia

October 25th 2022, 3:00pm

Article

The FDA granted a priority review to the oral drug quizartinib for the treatment of a form of acute myeloid leukemia, one of the more common types of leukemia.

From a Halfway House to Cancer Treatment: My Family Helped Me Live With ‘Profound Purpose’ After a Leukemia Relapse

October 25th 2022, 1:00pm

Article

After breaking 20 years of sobriety, I received even worse news: my leukemia had relapsed, and I’d need a bone marrow transplant. Thankfully, my family and treatment team lifted me up during this difficult time.

FDA Stops Study of Novel Blood Cancer Drug

August 23rd 2022, 9:00pm

Article

The Food and Drug Administration put a full clinical hold on a study of the novel drug FHD-286 in patients with acute myelogenous leukemia and myelodysplastic syndrome after study data showed an increase in a potentially fatal side effect.

First Patient Receives Investigational Cancer Drug-Combination for Relapsed/Refractory Acute Myeloid Leukemia

August 22nd 2022, 7:00pm

Article

Adding the investigational cancer drug lanraplenib to Xospata, if found to be effective, may broaden treatment options for patients with relapsed/refractory FLT3-mutated acute myeloid leukemia.

Trial to Compare Safety and Efficacy of Novel Cell Therapy to Standard of Care in Patients With Rare Blood Cancers

August 3rd 2022, 9:00pm

Article

Enrollment has begun on a phase 3 clinical trial assessing the safety and efficacy of an investigational cell therapy in patients with acute myeloid leukemia, acute lymphocytic leukemia and myelodysplastic syndromes.

Outcomes Are Best When Patients With Cancer Are as Aware of Their Disease as Their Provider, Expert Says

August 2nd 2022, 7:55pm

Video

Patients with cancer are encouraged to learn more about their disease from evidenced-based sources and not “Dr. Google.”

Novel Drug-Chemotherapy Combo After Stem Cell Transplant Associated With ‘Favorable Survival Outcomes’ in Group of Rare Blood Cancers

July 26th 2022, 7:00pm

Article

The findings support future studies of assessing the safety and efficacy of the novel drug-chemotherapy combination as a maintenance strategy following stem cell transplantation across a range of blood cancers, according to the study authors.

Tibsovo Plus Vidaza Is Beneficial for Patients With IDH1-Mutant Acute Myeloid Leukemia

June 4th 2022, 11:50pm

Article

Tibsovo plus Vidaza led to survival benefit for patients with IDH1-mutant acute myeloid leukemia, according to findings from the AGILE clinical trial.

Patient With Leukemia Subtype Undergoes Stem Cell Transplant After Receiving Novel Monotherapy in Early-Phase Trial

April 1st 2022, 7:00pm

Article

Treatment with a novel monotherapy in a patient with relapsed/refractory acute myeloid leukemia was effective enough that a successful, as indicated by a significant reduction in bone marrow blasts, stem cell transplant was performed.